JP2000507828A5 - - Google Patents

Download PDF

Info

Publication number
JP2000507828A5
JP2000507828A5 JP1997535410A JP53541097A JP2000507828A5 JP 2000507828 A5 JP2000507828 A5 JP 2000507828A5 JP 1997535410 A JP1997535410 A JP 1997535410A JP 53541097 A JP53541097 A JP 53541097A JP 2000507828 A5 JP2000507828 A5 JP 2000507828A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1997535410A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000507828A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1997/004966 external-priority patent/WO1997037228A1/en
Publication of JP2000507828A publication Critical patent/JP2000507828A/ja
Publication of JP2000507828A5 publication Critical patent/JP2000507828A5/ja
Ceased legal-status Critical Current

Links

JP9535410A 1996-03-29 1997-03-28 アルツハイマー病の診断および治療法 Ceased JP2000507828A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62576596A 1996-03-29 1996-03-29
US08/625,765 1996-03-29
PCT/US1997/004966 WO1997037228A1 (en) 1996-03-29 1997-03-28 Methods for diagnosing and treating alzheimer's disease

Publications (2)

Publication Number Publication Date
JP2000507828A JP2000507828A (ja) 2000-06-27
JP2000507828A5 true JP2000507828A5 (enExample) 2004-11-25

Family

ID=24507498

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9535410A Ceased JP2000507828A (ja) 1996-03-29 1997-03-28 アルツハイマー病の診断および治療法

Country Status (8)

Country Link
US (3) US6242416B1 (enExample)
EP (1) EP0890105B1 (enExample)
JP (1) JP2000507828A (enExample)
AT (1) ATE346303T1 (enExample)
AU (1) AU719038B2 (enExample)
CA (1) CA2250075C (enExample)
DE (1) DE69736976T2 (enExample)
WO (1) WO1997037228A1 (enExample)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6867179B1 (en) 1994-08-31 2005-03-15 Trustees Of Boston University Methods of inducing hair growth and coloration
US7196055B2 (en) * 1994-08-31 2007-03-27 Trustees Of Boston University Inhibition of apoptosis in keratinocytes by a ligand of p75 nerve growth factor receptor
EP0890105B1 (en) 1996-03-29 2006-11-22 The Trustees Of Boston University Methods related to Alzheimer's disease for diagnosis, manufacture of medicaments and screening of substances and beta-amyloid related peptides
EP1207897A2 (en) * 1999-08-09 2002-05-29 Tripep Ab Pharmaceutical compositions containing tripeptides
US6258932B1 (en) * 1999-08-09 2001-07-10 Tripep Ab Peptides that block viral infectivity and methods of use thereof
KR20020007432A (ko) * 2000-07-13 2002-01-29 박현석 멜라노트랜스페린에 대한 단클론 항체를 유효성분으로포함하는 알츠하이머병의 진단시약
US6593455B2 (en) * 2001-08-24 2003-07-15 Tripep Ab Tripeptide amides that block viral infectivity and methods of use thereof
US6455670B1 (en) * 2001-09-06 2002-09-24 Tripep Ab Pentamer peptide amide, ALGPG-NH2, that inhibits viral infectivity and methods of use thereof
EP1436317A1 (en) * 2001-09-19 2004-07-14 Tripep Ab Molecules that block viral infectivity and methods of use thereof
AUPS230702A0 (en) * 2002-05-14 2002-06-13 Walter And Eliza Hall Institute Of Medical Research, The A method of treatment
US20050096319A1 (en) * 2003-02-21 2005-05-05 Balzarini Jan M.R. Identification of compounds that inhibit replication of human immunodeficiency virus
HK1079984A1 (zh) * 2003-02-21 2006-04-21 Tripep Ab 抑制hiv复制的甘氨酰胺衍生物
WO2004087744A2 (en) * 2003-03-28 2004-10-14 Intellectual Property Consulting Inc. Composition and method for nerve regeneration
PL1625150T3 (pl) 2003-05-08 2007-05-31 Dsm Ip Assets Bv Tripeptydy i ich pochodne do stosowania w kosmetyce w celu poprawy struktury skóry
EP1718324A4 (en) * 2003-06-11 2009-07-15 Socratech L L C A SOLUBLE PROTEIN RELATED TO THE LOW DENSITY LIPOPROTEIN RECEPTOR BINDS DIRECTLY TO THE ALZHEIMER BETA AMYLOID PEPTIDE
EP1500399A1 (en) * 2003-07-24 2005-01-26 Institut Pasteur Active or passive immunization against proapoptotic neurotrophins for the treatment or prevention of neurodegenerative deseases
US20110230479A1 (en) * 2005-04-15 2011-09-22 Longo Frank M Neurotrophin mimetics and uses thereof
EP1871420A4 (en) * 2005-04-15 2010-09-22 Univ North Carolina PROCESS FOR ENABLING CELL SURVIVAL VIA NEUROTROPHINE MIMETICS
WO2006116400A2 (en) * 2005-04-27 2006-11-02 Massachusetts Institute Of Technology Promoter engineering and genetic control
WO2008050754A1 (fr) * 2006-10-23 2008-05-02 National University Corporation Nagoya University Inhibiteur de l'oxydation intracérébrale et utilisation de celui-ci
BRPI0921837A2 (pt) 2008-11-25 2016-01-12 Biogen Idec Inc anticorpos isolados ou fragmentos de antígeno de ligação dos mesmos que podem se ligar especificamente a um polipeptídio dr6, métodos in vitro de promover a sobrevivência de uma célula do sistema nervoso, usos de um antagonista dr6 e métodos in vitro de inibir a ligação de dr6 com p75
TW201034684A (en) * 2009-02-18 2010-10-01 Genentech Inc Method for inhibiting neurodegeneration
US9458427B2 (en) * 2009-08-07 2016-10-04 Case Western Reserve University IFNγR2 compositions and methods of inhibiting neuronal cell death
ES2712752T3 (es) 2009-11-12 2019-05-14 Pharmatrophix Inc Formas cristalinas de compuestos miméticos de neurotrofina y sus sales
CN102612374A (zh) * 2009-11-12 2012-07-25 霍夫曼-拉罗奇有限公司 提升树突棘密度的方法
US10273219B2 (en) 2009-11-12 2019-04-30 Pharmatrophix, Inc. Crystalline forms of neurotrophin mimetic compounds and their salts
US9216217B2 (en) * 2010-03-03 2015-12-22 The University Of British Columbia Oligomer-specific amyloid beta epitope and antibodies
AU2013205000B2 (en) * 2010-03-03 2015-05-28 The University Of British Columbia Oligomer-specific amyloid beta epitope and antibodies
ES2628596T3 (es) * 2010-11-29 2017-08-03 Akershus Universitetssykehus Procedimientos y composiciones para monitorizar la actividad fagocítica
US20140235496A1 (en) * 2011-10-05 2014-08-21 Blanchette Rockefeller Neurosciences Drive Stimulus-elicited genomic profile markers of a neurodegenerative condition
WO2013082045A1 (en) * 2011-11-28 2013-06-06 Buck Institute For Age Research Netrin loop peptide mimetics and uses thereof
GB2516045A (en) * 2013-07-09 2015-01-14 Neuro Bio Ltd Neurodegenerative disorders
EP2950095B1 (en) 2014-05-28 2018-08-29 Technische Universität Dresden Cell-based assay and screening methods for modulators of p75NTR signaling
CN116626310A (zh) * 2017-03-06 2023-08-22 刘军 Aβ-诱导的损伤的抑制或减轻药剂
CA3070446A1 (en) 2017-07-25 2019-01-31 Immutics, Inc. Treating cancer by blocking the interaction of tim-3 and its ligand
JP6359160B2 (ja) * 2017-07-25 2018-07-18 株式会社Mcbi 認知機能障害疾患のバイオマーカーおよび該バイオマーカーを用いる認知機能障害疾患の検出方法
CN120058944A (zh) 2019-01-30 2025-05-30 真和制药有限公司 抗gal3抗体及其用途
EP4157338A4 (en) 2020-05-26 2024-11-13 TrueBinding, Inc. METHOD FOR TREATING INFLAMMATORY DISEASES BY GALECTIN-3 BLOCKING
CN119661638B (zh) * 2024-11-22 2025-07-18 象山县第一人民医院医疗健康集团(宁波市第四医院、宁波市第四医院医院管理研究所) 一种修复神经损伤的多肽、制备方法及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5288641A (en) 1984-06-04 1994-02-22 Arch Development Corporation Herpes Simplex virus as a vector
US4918405A (en) * 1988-10-26 1990-04-17 Hewlett-Packard Company Signal generator utilizing a combined phase locked and frequency locked loop
FR2662355B1 (fr) * 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
US5618822A (en) * 1990-05-23 1997-04-08 Sanofi N-substituted trifluoromethylphenyltetrahydropyridines, process for the preparation thereof, intermediates in said process and pharmaceutical compositions containing them
IL101661A (en) * 1991-04-23 1998-02-08 Regeneron Pharma Method for detecting, identifying or measuring agents having neurotrophin activity
TW327194B (en) * 1992-05-01 1998-02-21 American Cyanamid Co Novel amyloid precursor proteins and methods of using same
US5976816A (en) 1993-05-03 1999-11-02 The United States Of America As Represented By The Department Of Health And Human Services Cell tests for alzheimer's disease
GB9402331D0 (en) * 1994-02-07 1994-03-30 Univ Mcgill Nerve growth factor structural analogs and their uses
US5576209A (en) 1994-10-24 1996-11-19 The Regents Of The University Of California Method for increasing the resistance of neural cells to β-amyloid peptide toxicity
EP0890105B1 (en) * 1996-03-29 2006-11-22 The Trustees Of Boston University Methods related to Alzheimer's disease for diagnosis, manufacture of medicaments and screening of substances and beta-amyloid related peptides

Similar Documents

Publication Publication Date Title
JP2000502280A5 (enExample)
JP2000501771A5 (enExample)
JP2000501599A5 (enExample)
JP2000501018A5 (enExample)
JP2000500076A5 (enExample)
JP2000501324A5 (enExample)
JP2000500055A5 (enExample)
JP2000502472A5 (enExample)
JP2000501825A5 (enExample)
JP2000501338A5 (enExample)
JP2000500874A5 (enExample)
JP2001503019A5 (enExample)
JP2000502425A5 (enExample)
JP2000502568A5 (enExample)
JP2000501774A5 (enExample)
JP2000500912A5 (enExample)
JP2000502570A5 (enExample)
JP2000507828A5 (enExample)
JP2000501876A5 (enExample)
JP2000501744A5 (enExample)
JP2000501229A5 (enExample)
JP2000502316A5 (enExample)
JP2000500857A5 (enExample)
JP2000502714A5 (enExample)
JP2000501569A5 (enExample)